CTL019 Out of Specification MAP for ALL or DLBCL Patients
Acute Lymphoblastic Leukemia (ALL) Diffuse Large B-cell Lymphoma (DLBCL) Acute Lymphoblastic Leukemia ALL Pediatric Diffuse Large b-cell Lymphoma DLBCL Adult Relapse Refractory CTL019 tisagenlecleucel Kymriah CART19 CART CAR T cells Chimeric antigen receptor Manufacturing Expanded Access Out of Specification Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Lymphoid Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse
Lead Scientists at University of California Health
- James Chng (ucla)
- Josh Sasine (ucla)
- Dimitrios Tzachanis (ucsd)
Associate Clinical Professor, Medicine. Authored (or co-authored) 47 research publications.
- Michelle Hermiston (ucsf)
Associate Professor, Pediatrics. Authored (or co-authored) 102 research publications.
- Charalambos Andreadis (ucsf)
- Christopher Seet (ucla)
Assistant Professor-in-Residence, Medicine. Authored (or co-authored) 18 research publications.
- not accepting new patients
- Start Date
- Novartis Pharmaceuticals
- Study Type
- Expanded Access
- Last Updated